Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: Comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution

Clinical Immunology

Volumn 133, Issue 2, 2009, Pages 238-244

  Murdaca, Giuseppe ^a   Contini, Paola ^a   Setti, Maurizio ^a   Cagnati, Paola ^a   Lantieri, Francesca ^b   Indiveri, Francesco ^a   Puppo, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

AIDS; HAART; HIV; Soluble HLA class I molecules; Soluble HLA G molecules

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; SOLUBLE HLA CLASS G ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIGEN DETECTION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MARKER; DRUG PROTEIN BINDING; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE MEMBRANE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RNA, VIRAL; SEX CHARACTERISTICS; T-LYMPHOCYTE SUBSETS;

EID: 70349785082     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.08.002     Document Type: Article

References (31)

1. Ploegh H.L., Orr H.T., and Strominger J.L. Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell 24 (1981) 287-299
2. O'Callaghan C.A., and Bell J.L. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163 (1998) 129-138
3. Krangel M.S., Orr H.T., and Strominger J.L. Assembly and maturation of HLA-A and HLA-B antigens in vivo. Cell 18 (1979) 979-991
4. Ploegh H.L., Orr H.T., and Strominger J.L. Major histocompatibilty antigens: the human (HLA-A, -B, -C) and murine (H-2k, H-2D) class I molecules. Cell 24 (1981) 287-299
5. Allison J.P., Pellegrino M.A., Ferrone S., Callahan G.N., and Reisfeld R.A. Biologic and chemical characterization of HLA antigens in human serum. J. Immunol. 118 (1977) 1004-1009
6. Pellegrino M.A., Russo C., and Allison J.P. HLA antigens in serum. Methods Enzymol. 108 (1984) 614-624
7. Krangel M.S. Secretion of HLA-A and-B antigens via an alternative RNA splicing pathway. J. Exp. Med. 163 (1986) 1173-1190
8. Krangel M.S. Two forms of HLA class I molecules in human plasma. Hum. Immunol. 20 (1987) 155-165
9. Dobbe L.M., Stam N.J., Neefjes J.J., and Giphart M.J. Biochemical complexity of serum HLA class I molecules. Immunogenetics 27 (1988) 203-210
10. Favier B., LeMaoult J., Rouas-Freiss N., Moreau P., Menier C., and Carosella ED. Research on HLA-G: an update. Tissue Antigens 69 (2007) 207-211
11. Carosella E.D., Favier B., Rouas-Freiss N., Moreau P., and LeMaoult J. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111 (2008) 4862-4870
12. 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet 339 (1992) 1436-1440
13. 2-microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency infection. Arch. Intern. Med. 150 (1990) 73-77
14. Fahey J.L., Taylor J.M.G., Detels R., Hofmann B., Melmed R., Nishanian P., and Giorgi J.V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322 (1990) 166-172
15. Puppo F., Brenci S., Lanza L., Bosco O., Imro M.A., Scudeletti M., Indiveri F., and Ferrone S. Increased level of serum HLA class I antigens in HIV infection. Correlation with disease progression. Hum. Immunol. 40 (1994) 259-266
16. Murdaca G., Contini P., Setti M., Cagnati P., Villa R., Lantieri F., Indiveri F., and Puppo F. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome. Hum. Immunol. 68 (2007) 894-900
17. Russo C., Fotino M., Carbonara A., and Ferrone S. A double determinant immunoassay for HLA class I typing using serum as an antigen source. Hum. Immunol. 19 (1987) 69-77
18. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., and Ziegler A.Z. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14 (1978) 9-20
19. Pellegrino M.A., Ng A.K., Russo C., and Ferrone S. Heterogeneous distribution of determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules. Transplantation 34 (1982) 18-23
20. Puppo F., Scudeletti M., Indiveri F., and Ferrone S. Serum HLA class I antigens: marker and modulators of an immune response?. Immunol. Today 16 (1995) 124-127
21. Tabayoyong W.B., and Zavazava N. Soluble HLA revisited. Leuk. Res. 31 (2007) 121-125
22. Fainardi E., Rizzo R., Melchiorri L., Stignani M., Castellazzi M., Tamborino C., Paolino E., Tola M.R., Granieri E., and Baricordi O.R. CSF levels of solubile HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis. Mult. Scler. 14 (2008) 446-454
23. Campoli M., and Ferrone S. Tumour escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands. Tissue Antigens 72 (2008) 321-334
24. Pistoia V., Morandi F., Wang X., and Ferrone S. Soluble HLA-G : Are they clinically relevant?. Semin. Cancer Biol. 17 (2007) 469-479
25. Lozano J.M., Gonzalez R., Kindelan J.M., Rouas-Freiss N., Caballos R., Dausset J., Carosella E.D., and Peña J. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16 (2002) 347-351
26. Donaghy L., Gros F., Amiot L., Mary C., Maillard A., Guiguen C., and Gangneux J.P. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin. Exp. Immunol. 147 (2007) 236-240
27. Aulitzky W.E., Grosse-Wilde H., Westhoff U., Tilg H., Aulitzky W., and Gastl G. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma). Clin. Exp. Immunol. 86 (1991) 236-239
28. Maio M., Gulwani B., Langer J.A., Kerbel R.S., Duigou G.J., Fisher P.B., and Ferrone S. Modulation by interferons of HLA antigen, high-molecular weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential. Cancer Res. 49 (1989) 2980-2987
29. Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., and Puppo F. Soluble HLA-A, -B, -C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur. J. Immunol. 33 (2003) 125-134
30. lck,calcium calmodulin kinase II, and calcium-independent protein kinase C signaling pathways and for NF-κB and NF-AT nuclear translocation. J. Immunol. 175 (2005) 7244-7254
31. Feger U., Tolosa E., Huang Y.H., Waschbisch A., Biedermann T., Melms A., and Wiendl H. HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation. Blood 110 (2007) 568-577